Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Culling The Pipeline: An Analysis Of Biogen's Discontinued Programs

Nov 22 2010

Related Content

Biogen Idec/Acorda Strike Licensing Deal For MS Candidate Fampridine-SR

Jul 01 2009

Biogen Idec Lays Off 13 Percent of Staff, Retrenches Around Multiple Sclerosis

Nov 08 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window